Understanding the costs of drug-related actions is an important aspect of drug policy.
In Germany, the drug policy documents do not systematically distinguish the actions or budgets for licit and illicit substances, which means that it is difficult to identify drug-related expenditure. Since the funding of most drug initiatives is the responsibility of the Länder, the federal government and local governments, as well as social security, information on drug-related expenditure is not aggregated regularly.
A study that estimated the total drug-related public expenditure for the year 2006 indicated that total drug- related expenditure was between 0.23 % and 0.26 % of gross domestic product (GDP). Of the total expenditure, which was estimated to be between EUR 5.2 billion and EUR 6.1 billion, the majority (64.8-69.5 %) was allocated to public order and safety, followed by expenditure on health and social protection (29.9- 34.4 %) and a small proportion was allocated to general coordination activities (less than 1 %). However, the expenditure attributed to social security may have been underestimated, as there are limited opportunities to link these expenditures to drug use or drug-related disorders.
The available information does not allow reporting on trends in drug-related public expenditures in Germany.
Public expenditure related to illicit drugs in Germany
NBBased on estimates of Germany’s labelled and unlabelled public expenditure in 2006